Home > Press > QuantumSphere Unveils Word’s First Pure Magnetic Nanopowder
Abstract:
Magnetic Nanopowders Significantly Advance Medical Diagnostic Results Previously Undetectable Using Conventional Technology
QuantumSphere Unveils Word’s First Pure Magnetic Nanopowder for Biomedical and Magnetic Resonance Imaging (MRI) Applications
Costa Mesa, CA | March 17, 2005
QuantumSphere today announced that
it has unveiled the first pure magnetic nanopowder for biomedical
applications. QuantumSphere produces, manufactures and sells magnetic
nanopowder based on a material that is not harmful to the body.
QuantumSphere’s magnetic nanopowder will be used to dramatically enhance
Magnetic Resonance Imaging (MRI) applications. MRI technology can be
leveraged in conjunction with QuantumSphere’s magnetic nanoparticles to
focus electromagnetic energy waves into the body to view internal organs
better, such as the liver, to see damage, or investigate the functions of
internal organs. QuantumSphere’s magnetic nanopowders offer
orders-of-magnitude performance improvements when compared to existing
imaging materials, such as gadolinium dies, and other standard materials
used today. Entities such as General Electric, Walter Reed Army Medical
Center, and leading academic institutions such as the Mayo Clinic can
significantly benefit from this advance.
“QuantumSphere’s introduction of magnetic nanopowders, backed by our
mass-scale manufacturing and production capability, marks a milestone in the
evolution of science, research and patient treatment. By leveraging our
magnetic nanopowders, research institutions and companies alike will enjoy
orders-of-magnitude performance improvements in MRI resolution and imaging,
better diagnoses and patient treatment,” said Dr. Douglas Carpenter, Chief
Scientific Officer and Director of Research and Development, QuantumSphere,
Inc. “QuantumSphere’s metallic nanopowders enable users to leverage
cutting-edge technology that vastly improves the understanding of disease
and organ function. The use of our product will ignite awareness and
advances in the MRI field as our nanopowders offer a breakthrough technology
that will drive new discoveries and patient analysis. Although the MRI field
is a multi-billion market, MRIs use materials such as gadolinium dies or
other processes that fail to produce the most efficient number of
resolutions to scans and signal to noise ratios. Our technology will solve
these issues,” Dr. Carpenter concluded.
QuantumSphere is the leading manufacturer of metallic nanopowders for
applications in the aerospace, defense, energy, biomedical and other markets
demanding advanced material applications. QuantumSphere enables
order-of-magnitude performance improvements for applications by using
nanotechnology in existing materials to make new, revolutionary products.
QuantumSphere is uniquely positioned to meet the market needs, as the firm’s
facility scales up to produce 2,500 pounds of the world’s purest
nanopowders, including nanonickel, a month.
About QuantumSphere, Inc.
QuantumSphere is the leading manufacturer of metallic nanopowders for
applications in the aerospace, defense, energy, biomedical and other markets
demanding advanced material applications. QuantumSphere’s exclusive
manufacturing process provides: consistent, narrow particle size
distribution; low level of agglomeration and impurities; custom-tailored
oxide shell thickness; and the highest purity metallic nanopowders on the
market that are easier to transport and handle. The company manufactures the
highest quality of metallic nanopowder in the industry without compromising
its commitment to the environment. No other company offers these performance
advantages.
QuantumSphere is the only supplier of the world’s highest quality nanonickel
(n-Ni). This will replace platinum as the main catalyst in hydrogen fuel
cells and provide a renewable source of power to supply the world’s energy
needs. The company is leveraging its leading market position in nanonickel
(n-Ni) to manufacture and ship product for applications in fuel cells,
magnetic medical products (e.g., contrast agent that is orders-of-magnitude
more sensitive than existing materials for MRI detection of disease and
organ function), and other applications including additives for plastics and
electromagnetic frequency shielding applications.
For more information, visit www.qsinano.com
Press Contact:
Joe Romano
781-279-1320 x 208
jromano@highgroundinc.com
Copyright ©
QuantumSphere
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
Possible Futures
Space Solar Power: Key to a Livable Planet Earth June 10th, 2013
Global Nanotechnology Drug Delivery Market 2012-2016 June 10th, 2013
Nanorobot tetanus treatment animation June 9th, 2013
New horizons to drive the future of Medicine: European Technology Platform on Nanomedicine intends to lead the domain June 8th, 2013
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Materials
Working backward: Computer-aided design of zeolite templates: Rice scientists apply drug-design lessons to production of industrial minerals June 17th, 2013
Discover the ‘Nanostructure Advantage’ at ECerS 2013, Booth 5: Innovnano presents nanostructured powders for high performance ceramics June 17th, 2013
Discovery of new material state counterintuitive to laws of physics June 14th, 2013
Ceramics in Paper Manufacturing including Advanced and Nano Materials: Author- Dr. Mahendra Patel, 420 pages; 32 chapters, Publ.2013 June 12th, 2013
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013